Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01528917 · ClinicalTrials.gov registry record
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
A clinical trial, sponsored by Alexion Pharmaceuticals.
- Completed
- Registry status
- 49
- Enrollment target
NCT01528917 is a clinical trial that has completed, run by Alexion Pharmaceuticals. The registered enrollment target is 49 participants.
The verdict
NCT01528917 has completed, sponsored by Alexion Pharmaceuticals.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
This is a Natural History study to characterize key aspects of the clinical course of late onset Lysosomal Acid Lipase (LAL) Deficiency/ Cholesteryl Ester Storage Disease (CESD).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01528917
The ClinicalTrials.gov registry entry for NCT01528917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexion Pharmaceuticals, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01528917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01528917 about?
NCT01528917 is a clinical study titled "An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype". This is a Natural History study to characterize key aspects of the clinical course of late onset Lysosomal Acid Lipase (LAL) Deficiency/ Cholesteryl Ester Storage Disease (CESD).
What is the current status of trial NCT01528917?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2011-06. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01528917?
This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.